Ratnakar Securities Pvt. Ltd.

AARTI PHARMALABS LTD.

NSE : AARTIPHARMBSE : 543748ISIN CODE : INE0LRU01027Industry : Pharmaceuticals & DrugsHouse : Private

BSE739.809.55 (+1.31 %)

PREV CLOSE ( ) 730.25

OPEN PRICE ( ) 737.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 6978

TODAY'S LOW / HIGH ( )728.55 749.05

52 WK LOW / HIGH ( )380.65 837

Select year

Particulars	Mar2024	Mar2023	Mar2022	Mar2021
Operational & Financial Ratios
Earnings Per Share (Rs)	23.93	21.35	4890.04	-0.18
CEPS(Rs)	32.01	28.25	6574.79	-0.18
DPS(Rs)	3.00	2.00	0.00	0.00
Book NAV/Share(Rs)	193.85	171.97	53646.60	9.12
Tax Rate(%)	27.82	25.80	21.32	0.00
Margin Ratios
Core EBITDA Margin(%)	20.84	17.58	17.11
EBIT Margin(%)	17.15	14.49	13.95
Pre Tax Margin(%)	16.22	13.41	12.95
PAT Margin (%)	11.71	9.95	10.19
Cash Profit Margin (%)	15.66	13.16	13.70
Performance Ratios
ROA(%)	8.99	9.03	11.98	-1.84
ROE(%)	13.08	13.35	18.23	-2.02
ROCE(%)	16.75	16.11	19.40	-1.87
Asset Turnover(x)	0.77	0.91	1.18	0.00
Sales/Fixed Asset(x)	1.22	1.46	0.98
Working Capital/Sales(x)	2.84	3.46	2.68	0.00
Efficiency Ratios
Fixed Capital/Sales(x)	0.82	0.68	1.02
Receivable days	95.50	77.57	114.57
Inventory Days	122.63	101.09	144.62
Payable days	128.34	86.45	61.41
Valuation Parameters
PER(x)	18.18	12.86	0.00	0.00
PCE(x)	13.59	9.72	0.00	0.00
Price/Book(x)	2.24	1.60	0.00	0.00
Yield(%)	0.69	0.73
EV/Net Sales(x)	2.26	1.38	0.21
EV/Core EBITDA(x)	10.70	7.81	1.22	-3.76
EV/EBIT(x)	13.16	9.55	1.53	-3.76
EV/CE(x)	2.07	1.52	0.15	0.07
M Cap / Sales	2.13	1.28	0.00
Growth Ratio
Net Sales Growth(%)	-4.76	62.11
Core EBITDA Growth(%)	13.52	64.41	0.00	0.00
EBIT Growth(%)	12.73	68.42	0.00	0.00
PAT Growth(%)	12.10	58.28	0.00	0.00
EPS Growth(%)	12.10	-99.56	0.00	0.00
Financial Stability Ratios
Total Debt/Equity(x)	0.15	0.14	0.25	0.08
Current Ratio(x)	1.94	1.94	1.77	11.42
Quick Ratio(x)	1.01	0.93	0.95	11.42
Interest Cover(x)	18.46	13.39	13.99
Total Debt/Mcap(x)	0.07	0.09

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Financial Ratios

AARTI PHARMALABS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES